De novo pyrimidine synthesis controls lupus-prone germinal center B cell and plasma cell fates 2304696

J Julia Weber K Kristen Bricker (Thomas Jefferson University) T Tien Bui (Thomas Jefferson University) S Sathi Babu Chodisetti (Thomas Jefferson University) S Sophia Crocker (Thomas Jefferson University) A Adam Fike (Penn State University) A Aaron Goldman (The Wistar Institute) A Anju Maharjan (Thomas Jefferson University) K Keomonyroth Nuon (Thomas Jefferson University) Z Ziaur Rahman W Wujuan Zhang (The Wistar Institute)

Abstract

Abstract Introduction The role of pyrimidine metabolites in SLE-prone germinal center (GC) and plasma cell (PC) responses is unknown. Methods A combination of steady-state metabolomics analysis and isotopic 15N-glutamine tracing were used to examine metabolic flux through de novo pyrimidine synthesis pathway in SLE-prone B cells. To examine role of the de novo pyrimidine synthesis pathway in the SLE autoimmune phenotype, global inhibition in SLE-prone mice was tested first, then UMPS conditional knockout SLE-prone mice were generated and phenotyped. Steady-state metabolomics, mitochondrial stress test, and metabolic flow cytometry were employed to elucidate a role for de novo pyrimidine synthesis in regulating metabolic pathways. Results Metabolomics and 15N-amide glutamine tracing reveal enhanced flux through pyrimidine synthesis in SLE-prone B cells. Global inhibition of de novo pyrimidine synthesis in SLE-prone mice dampened GC, PC and autoantibody responses, and kidney immune complex (IC) deposition. This inhibition did not overtly affect foreign antigen-driven GC, PC, and antibody responses. Newly generated UMPS conditional knockout SLE-prone mice revealed a B cell-intrinsic requirement of de novo pyrimidine synthesis in spontaneous GC, PC and autoantibody responses, and kidney IC deposition. Metabolomics, mitochondrial stress-test and metabolic flow cytometry helped delineate a crucial role for pyrimidine synthesis in B cell metabolic reprogramming that promotes autoimmunity. Mechanistically, mTORC1 and S6K1 downstream of TLR7 and CD40 signaling in B cells activate CAD, which catalyzes the first three steps of pyrimidine synthesis and upregulates de novo pyrimidine synthesis. Conclusion We identify a previously unknown B cell-intrinsic requirement of the pyrimidine pathway in autoimmune GC and PC responses, development of autoreactive B cells, and autoantibodies in SLE. Funding Source RO1 AI162971 RO1 AI194568 Finkelstein Memorial Student Research Award Topic Categories Basic Autoimmunity (BA)

Article Details

Volume / Issue Vol. 215, Issue Supplement_1
Published August 01, 2026
ISSN 0022-1767
Publisher American Association of Immunologists

Authors (11)

J

Julia Weber

K

Kristen Bricker

Thomas Jefferson University

T

Tien Bui

Thomas Jefferson University

S

Sathi Babu Chodisetti

Thomas Jefferson University

S

Sophia Crocker

Thomas Jefferson University

A

Adam Fike

Penn State University

A

Aaron Goldman

The Wistar Institute

A

Anju Maharjan

Thomas Jefferson University

K

Keomonyroth Nuon

Thomas Jefferson University

Z

Ziaur Rahman

W

Wujuan Zhang

The Wistar Institute